Shaolin Capital Management’s Coeptis Therapeutics COEP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-500
| Closed | -$2.97K | – | 334 |
|
|
2024
Q1 | $2.97K | Hold |
500
| – | – | ﹤0.01% | 332 |
|
|
2023
Q4 | $7.84K | Sell |
500
-1,750
| -78% | -$27.4K | ﹤0.01% | 336 |
|
|
2023
Q3 | $52K | Hold |
2,250
| – | – | ﹤0.01% | 298 |
|
|
2023
Q2 | $70K | Buy |
+2,250
| New | +$70K | ﹤0.01% | 135 |
|
|
2022
Q4 | – | Sell |
-8,250
| Closed | -$1.68M | – | 794 |
|
|
2022
Q3 | $1.68M | Hold |
8,250
| – | – | 0.05% | 369 |
|
|
2022
Q2 | $1.66M | Sell |
8,250
-24,750
| -75% | -$4.99M | 0.04% | 423 |
|
|
2022
Q1 | $6.66M | Hold |
33,000
| – | – | 0.17% | 162 |
|
|
2021
Q4 | $6.6M | Buy |
33,000
+15,500
| +89% | +$3.1M | 0.17% | 154 |
|
|
2021
Q3 | $3.48M | Hold |
17,500
| – | – | 0.11% | 232 |
|
|
2021
Q2 | $3.46M | Hold |
17,500
| – | – | 0.11% | 214 |
|
|
2021
Q1 | $3.42M | Sell |
17,500
-7,500
| -30% | -$1.47M | 0.14% | 155 |
|
|
2020
Q4 | $5.1M | Buy |
+25,000
| New | +$5.1M | 0.36% | 72 |
|